{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:53:52Z","timestamp":1781074432362,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T00:00:00Z","timestamp":1365638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Hematol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/2052-1839-13-4","type":"journal-article","created":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T16:15:53Z","timestamp":1365696953000},"source":"Crossref","is-referenced-by-count":28,"title":["Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab"],"prefix":"10.1186","volume":"13","author":[{"given":"Trine H","family":"Mogensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Magnus","family":"Bernth-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte C","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel S","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Nyvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten H","family":"Gadegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Hokland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hokland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten S","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,11]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","volume":"120","author":"RS Geha","year":"2007","unstructured":"Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, et al: Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007, 120: 776-794. 10.1016\/j.jaci.2007.08.053.","journal-title":"J Allergy Clin Immunol"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-385991-4.00002-7","volume":"111","author":"PF Yong","year":"2011","unstructured":"Yong PF, Thaventhiran JE, Grimbacher B: \"A rose is a rose is a rose,\" but CVID is Not CVID commonvariable immune deficiency (CVID), what do we know in 2011. Adv Immunol. 2011, 111: 47-107.","journal-title":"Adv Immunol"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1007\/s10875-008-9182-7","volume":"28","author":"C Cunningham-Rundles","year":"2008","unstructured":"Cunningham-Rundles C: Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol. 2008, 28: S42-S45. 10.1007\/s10875-008-9182-7.","journal-title":"J Clin Immunol"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1053\/j.seminhematol.2010.01.010","volume":"47","author":"R Stasi","year":"2010","unstructured":"Stasi R: Rituximab in autoimmune hematologic diseases: not just a matter of B cells. Semin Hematol. 2010, 47: 170-179. 10.1053\/j.seminhematol.2010.01.010.","journal-title":"Semin Hematol"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1182\/blood-2010-09-306910","volume":"116","author":"TB Russell","year":"2010","unstructured":"Russell TB, Kurre P: Double-negative T cells are non-ALPS-specific markers of immune dysregulation found in patients with aplastic anemia. Blood. 2010, 116: 5072-5073. 10.1182\/blood-2010-09-306910.","journal-title":"Blood"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000337051","volume":"127","author":"MC Garcia-Dabrio","year":"2012","unstructured":"Garcia-Dabrio MC, Pujol-Moix N, Martinez-Perez A, Fontcuberta J, Souto JC, Soria JM, et al: Influence of age, gender and lifestyle in lymphocyte subsets: report from the Spanish Gait-2 Study. Acta Haematol. 2012, 127: 244-249. 10.1159\/000337051.","journal-title":"Acta Haematol"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","volume":"112","author":"H Chapel","year":"2008","unstructured":"Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, et al: Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008, 112: 277-286. 10.1182\/blood-2007-11-124545.","journal-title":"Blood"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","volume":"99","author":"K Warnatz","year":"2002","unstructured":"Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G, et al: Severe deficiency of switched memory B cells (CD27(+)IgM(\u2212)IgD(\u2212)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002, 99: 1544-1551. 10.1182\/blood.V99.5.1544.","journal-title":"Blood"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s10875-010-9424-3","volume":"30","author":"G Mouillot","year":"2010","unstructured":"Mouillot G, Carmagnat M, Gerard L, Garnier JL, Fieschi C, Vince N, et al: B-Cell and T-Cell Phenotypes in CVID patients correlate with the clinical phenotype of the disease. J Clin Immunol. 2010, 30: 746-755. 10.1007\/s10875-010-9424-3.","journal-title":"J Clin Immunol"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al: The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008, 111: 77-85. 10.1182\/blood-2007-06-091744.","journal-title":"Blood"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.clim.2007.04.012","volume":"124","author":"AK Knight","year":"2007","unstructured":"Knight AK, Radigan L, Marron T, Langs A, Zhang L, Cunningham-Rundles C: High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency. Clin Immunol. 2007, 124: 182-189. 10.1016\/j.clim.2007.04.012.","journal-title":"Clin Immunol"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.4049\/jimmunol.165.8.4725","volume":"165","author":"D Bonhomme","year":"2000","unstructured":"Bonhomme D, Hammarstrom L, Webster D, Chapel H, Hermine O, Le Deist F, et al: Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Immunol. 2000, 165: 4725-4730.","journal-title":"J Immunol"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11882-009-0051-0","volume":"9","author":"S Agarwal","year":"2009","unstructured":"Agarwal S, Cunningham-Rundles C: Autoimmunity in common variable immunodeficiency. Curr Allergy Asthma Rep. 2009, 9: 347-352. 10.1007\/s11882-009-0051-0.","journal-title":"Curr Allergy Asthma Rep"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1182\/asheducation-2009.1.139","volume":"2009","author":"LD Notarangelo","year":"2009","unstructured":"Notarangelo LD: Primary immunodeficiencies (PIDs) presenting with cytopenias. Hematology Am Soc Hematol Educ Program. 2009, 2009: 139-143. 10.1182\/asheducation-2009.1.139.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.jaci.2011.02.039","volume":"127","author":"JS Orange","year":"2011","unstructured":"Orange JS, Glessner JT, Resnick E, Sullivan KE, Lucas M, Ferry B, et al: Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol. 2011, 127: 1360-1U79. 10.1016\/j.jaci.2011.02.039.","journal-title":"J Allergy Clin Immunol"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaut.2005.04.006","volume":"25","author":"J Wang","year":"2005","unstructured":"Wang J, Cunningham-Rundles C: Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun. 2005, 25: 57-62. 10.1016\/j.jaut.2005.04.006.","journal-title":"J Autoimmun"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.md.0000133624.65946.40","volume":"83","author":"M Michel","year":"2004","unstructured":"Michel M, Chanet V, Galicier L, Ruivard M, Levy Y, Hermine O, et al: Autoimmune thrombocytopenic purpura and common variable immunodeficiency - analysis of 21 cases and review of the literature. Medicine. 2004, 83: 254-263. 10.1097\/01.md.0000133624.65946.40.","journal-title":"Medicine"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1023\/A:1008416911099","volume":"9","author":"NL Berinstein","year":"1998","unstructured":"Berinstein NL, Grillo-Lopez AJ, White CA, Bence-Bruckler I, Maloney D, Czuczman M, et al: Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol. 1998, 9: 995-1001. 10.1023\/A:1008416911099.","journal-title":"Ann Oncol"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1365-2249.2009.03979.x","volume":"157","author":"MC Levesque","year":"2009","unstructured":"Levesque MC: Translational mini-review series on B cell-directed therapies: recent advances in B cell-directed biological therapies for autoimmune disorders. Clin Exp Immunol. 2009, 157: 198-208. 10.1111\/j.1365-2249.2009.03979.x.","journal-title":"Clin Exp Immunol"},{"key":"6_CR20","volume-title":"J Rheumatol","author":"EC Keystone","year":"2012","unstructured":"Keystone EC, Cohen SB, Emery P, Kremer JM, Dougados M, Loveless JE, et al: Multiple courses of Rituximab produce sustained clinical and radiographic efficacy and safety in patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors: 5-year data from the REFLEX study. J Rheumatol. 2012, Epub ahead of print"},{"key":"6_CR21","first-page":"CD009130","volume":"7","author":"D He","year":"2011","unstructured":"He D, Zhou H, Han W, Zhang S: Rituximab for relapsing-remitting multiple sclerosis. Cochrane Database Syst Rev. 2011, 7: CD009130-","journal-title":"Cochrane Database Syst Rev"},{"key":"6_CR22","volume-title":"Arthritis Rheum","author":"RM Smith","year":"2012","unstructured":"Smith RM, Jones RB, Guerry MJ, Laurino S, Catapano F, Chaudhry A, et al: Rituximab for remission maintenance in relapsing ANCA-associated vasculitis. Arthritis Rheum. 2012, Epub ahead of print"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrneph.2012.141","volume":"8","author":"JW Gregersen","year":"2012","unstructured":"Gregersen JW, Jayne DR: B-cell depletion in te treatment of lupus nephritis. Nat Rev Nephrol. 2012, 8: 505-514. 10.1038\/nrneph.2012.141.","journal-title":"Nat Rev Nephrol"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7326\/0003-4819-146-1-200701020-00006","volume":"146","author":"DM Arnold","year":"2007","unstructured":"Arnold DM, Dentali F, Crowther MA, Meyer RM, Cook RJ, Sigouin C, et al: Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007, 146: 25-W5. 10.7326\/0003-4819-146-1-200701020-00006.","journal-title":"Ann Intern Med"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","volume":"115","author":"D Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al: International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010, 115: 168-186. 10.1182\/blood-2009-06-225565.","journal-title":"Blood"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1046\/j.1365-2141.2003.04385.x","volume":"121","author":"K Chaiwatanatorn","year":"2003","unstructured":"Chaiwatanatorn K, Lee N, Grigg A, Filshie R, Firkin F: Delayed-onset neutropenia associated with rituximab therapy. Br J Haematol. 2003, 121: 913-918. 10.1046\/j.1365-2141.2003.04385.x.","journal-title":"Br J Haematol"},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.intimp.2008.10.004","volume":"9","author":"HM Gurcan","year":"2009","unstructured":"Gurcan HM, Keskin DB, Stern JNH, Nitzberg MA, Shekhani H, Ahmed AR: A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol. 2009, 9: 10-25. 10.1016\/j.intimp.2008.10.004.","journal-title":"Int Immunopharmacol"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1365-2141.2011.08880.x","volume":"155","author":"D Gobert","year":"2011","unstructured":"Gobert D, Bussel JB, Cunningham-Rundles C, Galicier L, Dechartres A, Berezne A, et al: Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. Br J Haematol. 2011, 155: 498-508. 10.1111\/j.1365-2141.2011.08880.x.","journal-title":"Br J Haematol"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0167-5699(94)90276-3","volume":"15","author":"TE Tedder","year":"1994","unstructured":"Tedder TE, Engel P: Cd20 - a regulator of cell-cycle progression of B-lymphocytes. Immunol Today. 1994, 15: 450-454. 10.1016\/0167-5699(94)90276-3.","journal-title":"Immunol Today"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cyto.990140212","volume":"14","author":"LE Hultin","year":"1993","unstructured":"Hultin LE, Hausner MA, Hultin PM, Giorgi JV: Cd20 (Pan-B Cell) antigen is expressed at a low-level on a subpopulation of human lymphocytes-T. Cytometry. 1993, 14: 196-204. 10.1002\/cyto.990140212.","journal-title":"Cytometry"},{"key":"6_CR31","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood.V100.6.2257","volume":"100","author":"LE van der Kolk","year":"2002","unstructured":"van der Kolk LE, Baars JW, Prins MH, Van Oers MHJ: Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood. 2002, 100: 2257-2259.","journal-title":"Blood"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MOH.0b013e3282a4a68b","volume":"14","author":"B Andemariam","year":"2007","unstructured":"Andemariam B, Bussel J: New therapies for immune thrombocytopenic purpura. Curr Opin Hematol. 2007, 14: 427-431. 10.1097\/MOH.0b013e3282a4a68b.","journal-title":"Curr Opin Hematol"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","volume":"8","author":"MK Slifka","year":"1998","unstructured":"Slifka MK, Antia R, Whitmire JK, Ahmed R: Humoral immunity due to long-lived plasma cells. Immunity. 1998, 8: 363-372. 10.1016\/S1074-7613(00)80541-5.","journal-title":"Immunity"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3899\/jrheum.090856","volume":"37","author":"R Van Vollenhoven","year":"2010","unstructured":"Van Vollenhoven R, Bessette L, Emery P: Long-term safety of rituximab: long-term follow-up of the RA clinical trials and retreatment population. J Rheumatol. 2010, 37: 1320-","journal-title":"J Rheumatol"},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/07357900701809068","volume":"26","author":"AR Walker","year":"2008","unstructured":"Walker AR, Kleiner A, Rich L, Conners C, Fisher RI, Anolik J, et al: Profound hypogammaglobulinemia 7 years after treatment for indolent lymphoma. Cancer Invest. 2008, 26: 431-433. 10.1080\/07357900701809068.","journal-title":"Cancer Invest"},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1600-0609.2006.00693.x","volume":"77","author":"M Nishio","year":"2006","unstructured":"Nishio M, Fujimoto K, Yamamoto S, Endo T, Sakai T, Obara M, et al: Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma. Eur J Haematol. 2006, 77: 226-232. 10.1111\/j.1600-0609.2006.00693.x.","journal-title":"Eur J Haematol"},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/jcp.2009.068940","volume":"63","author":"L Diwakar","year":"2010","unstructured":"Diwakar L, Gorrie S, Richter A, Chapman O, Dhillon P, Al Ghanmi F, et al: Does rituximab aggravate pre-existing hypogammaglobulinaemia. J Clin Pathol. 2010, 63: 275-277. 10.1136\/jcp.2009.068940.","journal-title":"J Clin Pathol"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1600-0609.2005.00552.x","volume":"75","author":"M Nishio","year":"2005","unstructured":"Nishio M, Endo T, Fujimoto K, Sato N, Sakai T, Obara M, et al: Persistent panhypogammaglobulinemia with selected loss of memory B cells and impaired isotype expression after rituximab therapy for post-transplant EBV-associated autoimmune hemolytic anemia. Eur J Haematol. 2005, 75: 527-529. 10.1111\/j.1600-0609.2005.00552.x.","journal-title":"Eur J Haematol"},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1196\/annals.1361.111","volume":"1051","author":"J Carbone","year":"2005","unstructured":"Carbone J, Escudero A, Mayayo M, Ballesteros M, Perez-Corral A, Sanchez-Ramon S, et al: Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. Ann Ny Acad Sci. 2005, 1051: 666-671. 10.1196\/annals.1361.111.","journal-title":"Ann Ny Acad Sci"},{"key":"6_CR40","first-page":"259","volume":"20","author":"M Al Ahmad","year":"2010","unstructured":"Al Ahmad M, Al Rasheed M, Al Muhani A: Successful use of rituximab in refractory idiopathic thrombocytopenic purpura in a patient with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2010, 20: 259-262.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/ajh.20619","volume":"81","author":"M Mahevas","year":"2006","unstructured":"Mahevas M, Le Page L, Salle V, Cevallos R, Smail A, Duhaut P, et al: Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency. Am J Hematol. 2006, 81: 645-646.","journal-title":"Am J Hematol"},{"key":"6_CR42","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/jcp.2006.041426","volume":"60","author":"TM El Shanawany","year":"2007","unstructured":"El Shanawany TM, Williams PE, Jolles S: Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab. J Clin Pathol. 2007, 60: 715-716. 10.1136\/jcp.2006.041426.","journal-title":"J Clin Pathol"},{"key":"6_CR43","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.clim.2010.08.008","volume":"137","author":"A Rensing-Ehl","year":"2010","unstructured":"Rensing-Ehl A, Warnatz K, Fuchs S, Schlesier M, Salzer U, Draeger R, et al: Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency. Clin Immunol. 2010, 137: 357-365. 10.1016\/j.clim.2010.08.008.","journal-title":"Clin Immunol"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jaci.2011.01.046","volume":"127","author":"TW Kuijpers","year":"2011","unstructured":"Kuijpers TW, Baars PA, De Kerk DJA, Jansen MH, Dors N, Van Lier RAW, et al: Common variable immunodeficiency and hemophagocytic features associated with a FAS gene mutation. J Allergy Clin Immunol. 2011, 127: 1411-1414. 10.1016\/j.jaci.2011.01.046.","journal-title":"J Allergy Clin Immunol"},{"key":"6_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.clim.2008.09.009","volume":"130","author":"L Martinez-Gamboa","year":"2009","unstructured":"Martinez-Gamboa L, Mei H, Loddenkemper C, Ballmer B, Hansen A, Lipsky PE, et al: Role of the spleen in peripheral memory B-cell homeostasis in patients with autoimmune thrombocytopenia purpura. Clin Immunol. 2009, 130: 199-212. 10.1016\/j.clim.2008.09.009.","journal-title":"Clin Immunol"},{"key":"6_CR46","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0301-0546(04)79242-3","volume":"32","author":"J Carbone","year":"2004","unstructured":"Carbone J, Sarmiento E, Rodriquez-Molina JJ, Fernandez-Cruz E: Atypical presentation of common variable immunodeficiency without infections. Allergol Immunopathol. 2004, 32: 218-222.","journal-title":"Allergol Immunopathol"},{"key":"6_CR47","volume-title":"Rev Med Interne","author":"P Seve","year":"2012","unstructured":"Seve P, Broussolle C, Pavic M: Primary immunodeficiencies presenting with autoimmune cytopenias in adults. Rev Med Interne. 2012, Epub ahead of print"}],"container-title":["BMC Blood Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2052-1839-13-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2052-1839-13-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2052-1839-13-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2052-1839-13-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T07:46:29Z","timestamp":1595663189000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchematol.biomedcentral.com\/articles\/10.1186\/2052-1839-13-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,11]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1186\/2052-1839-13-4","relation":{},"ISSN":["1471-2326"],"issn-type":[{"value":"1471-2326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,11]]},"article-number":"4"}}